Evidence map›Paper›PMID 41655237›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Mitochondrial CircRNA CircMT-RNR2 Safeguards Antioxidant Defense to Support Fibroblast Functions in Wound Repair.

Guanglin Niu, Jennifer Geara, Yongjian Chen, Lihua Luo, Yanwei Xiao, Zhuang Liu, Margaux Gaborieau, Ling Pan, Edmund Loh, Dongqing Li and 4 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Guanglin NiuDermatology and Venereology Division, Department of Medicine (Solna), Center For Molecular Medicine, Karolinska Institute, Stockholm, Sweden.
Jennifer GearaDermatology and Venereology Division, Department of Medicine (Solna), Center For Molecular Medicine, Karolinska Institute, Stockholm, Sweden.ORCID https://orcid.org/0000-0003-2367-7025
Yongjian ChenDermatology and Venereology Division, Department of Medicine (Solna), Center For Molecular Medicine, Karolinska Institute, Stockholm, Sweden.
Lihua LuoDermatology and Venereology Division, Department of Medicine (Solna), Center For Molecular Medicine, Karolinska Institute, Stockholm, Sweden.
Yanwei XiaoDepartment of Dermatology, The Second Hospital of Dalian Medical University, College of Integrative Medicine, Dalian Medical University, Dalian, China.
Zhuang LiuDermatology and Venereology Division, Department of Medicine (Solna), Center For Molecular Medicine, Karolinska Institute, Stockholm, Sweden.
Margaux GaborieauDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solna, Sweden.ORCID https://orcid.org/0009-0003-5976-9105
Ling PanJiangsu Provincial Key Laboratory of Dermatology, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China.
Edmund LohDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solna, Sweden.ORCID https://orcid.org/0000-0001-7050-566X
Dongqing LiJiangsu Provincial Key Laboratory of Dermatology, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China.
Pehr SommarDepartment of Plastic and Reconstructive Surgery, Karolinska University Hospital, Sweden and Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.
Aoxue WangDepartment of Dermatology, The Second Hospital of Dalian Medical University, College of Integrative Medicine, Dalian Medical University, Dalian, China.
Xiaowei ZhengDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Ning Xu LandénDermatology and Venereology Division, Department of Medicine (Solna), Center For Molecular Medicine, Karolinska Institute, Stockholm, Sweden.ORCID https://orcid.org/0000-0003-4868-3798

Funding

Åke Wiberg StiftelseKarolinska Institutet 2022-02284LEO Fondet LF-AW_EMEA-20-400022Ming Wai Lau Centre for Reparative MedicinePostdoctoral Fellowship from the Strategic Research Programme in Diabetes at Karolinska InstitutetSwedish Research Council 2020-01400 2024-02739Swedish Research Council 2021-02945Welander and Finsens Foundation
6 · The paper itself

Abstract

Diabetic foot ulcers (DFUs) are a debilitating diabetes complication in which mitochondrial dysfunction and oxidative stress are prominent but mechanistically unresolved features. Here, we identify the mitochondria-encoded circular RNA (mecciRNA) circMT-RNR2 as a novel modulator of mitochondrial redox homeostasis in human skin wound healing. CircMT-RNR2 is reduced in DFU patient tissue and diabetic mouse wounds, enriched in dermal fibroblasts, and localized to mitochondria. Its loss impairs fibroblast proliferation, migration, extracellular matrix production, and contraction by destabilizing the mitochondrial antioxidant protein PRDX3, leading to elevated oxidative stress, mitochondrial damage, and mitophagy. In murine and human ex vivo wound models, circMT-RNR2 knockdown delays healing, whereas overexpression accelerates repair and boosts antioxidant defenses. These findings position circMT-RNR2 as a mitochondrial guardian of skin healing and a promising therapeutic target for DFU.

Indexed as

AntioxidantsFibroblastsMitochondriaRNA, CircularWound HealingAnimalsHumansMiceOxidative StressSkinAntioxidantsRNA, CircularcircRNADFUmitochondriawound healing

Identifiers

PMID41655237
PMCPMC13159150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.